This study reveals a new signaling pathway, Snhg3/SND1/H3K27me3/PPARγ, responsible for hepatic steatosis and provides evidence of lncRNA-mediated epigenetics in the pathophysiology of MASLD (Figure 8G). The gene discussed is SNHG3; the disease is metabolic dysfunction-associated steatotic liver disease.